SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026778
Filing Date
2024-08-14
Accepted
2024-08-14 16:01:40
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pirs20240630_10q.htm   iXBRL 10-Q 1130803
2 EXHIBIT 10.1 ex_708983.htm EX-10.1 42972
3 EXHIBIT 10.2 ex_708984.htm EX-10.2 1062
4 EXHIBIT 31.1 ex_682568.htm EX-31.1 8576
5 EXHIBIT 31.2 ex_682569.htm EX-31.2 9280
6 EXHIBIT 32.1 ex_682570.htm EX-32.1 4237
7 EXHIBIT 32.2 ex_682571.htm EX-32.2 4223
13 a01.jpg GRAPHIC 203988
  Complete submission text file 0001437749-24-026778.txt   5490349

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240630.xsd EX-101.SCH 49961
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20240630_cal.xml EX-101.CAL 28283
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240630_def.xml EX-101.DEF 339906
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240630_lab.xml EX-101.LAB 268973
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240630_pre.xml EX-101.PRE 358071
69 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240630_10q_htm.xml XML 703411
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 241207294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)